GettyImages-609179959-hero

Cardiovascular Medicine

Heart Failure Clinical Trials

CORVIA: REDUCE-LAP-HF

View CORVIA: REDUCE-LAP-HF information

Evaluates the clinical efficacy and safety of the IASD System II in symptomatic heart failure patients with an LV ejection fraction ≥40%, and elevated left sided filling pressures despite standard Guideline Directed Medical Therapy (GDMT).


Primary Investigator: Michael Salinger, MD
Subinvestigator: Mitchell Saltzberg, MD; Nunzio Gaglianello, MD, Nicole Lohr, MD, PhD.

Status: Currently enrolling
Sub Category: Advanced Heart Failure

Meet Our Team

headshot

Nunzio Gaglianello, MD

Assistant Professor; Director of the Cardiovascular Medicine Fellowship

headshot

Nicole Lohr, MD, PhD, FACC

Associate Professor, Medical Director Cardiovascular Clinical Trials

headshot

Mitchell T. Saltzberg, MD, FACC, FAHA, FHFSA, MSc

Medical Director, Comprehensive Heart Failure; Professor

Cardiovascular Clinical Trials

The Cardiovascular Research Service is currently conducting drug and/or device trials in the cardiac subspecialties listed. However, this does not limit what we may be working on tomorrow.

Please contact the Cardiovascular Trials program by calling (414) 955-7021 or at DOMCVClinTriStaff@mcw.edu.